Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet

International Journal of Obesity

Volumn 21, Issue 4, 1997, Pages 280-283

  Jemaa, R ^a   Tuzet, S ^a   Betoulle, D ^a   Apfelbaum, M ^a   Fumeron, F ^a,b  

^a Inst Natl de la Sante Recherche   (France)

^b INSERM   (France)

Author keywords

DNA polymorphism; Lipoprotein lipase; Lipoproteins; Low calorie diet; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HOMOZYGOTE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030887071     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800401     Document Type: Article

References (21)

1. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med 1985; 104: 983-988.
2. Kissebah AH, Freedman DS, Peiris AN. Health risks of obesity. Med Clin North Am 1989; 73: 111-137.
3. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693-707.
4. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 1989; 79: 85-91.
5. Thorn JA, Chamberlain JC, Alcolado JC, Oka K, Chan L, Stocks J, Galton DJ. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 1990; 85: 55-60.
6. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992; 97: 171-185.
7. Ahn YI, Kamboh MI, Hamman RF, Cole SA, Ferrell RE. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 1993; 34: 421-428.
8. Heinzmann C, Kirchgessner T, Kwiterovich PO, Ladias JA, Derby C, Antonarakis SE and Lusis AJ. DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet 1991; 86: 578-584.
9. Mattu RK, Needham EWA, Morgan R, Rees A, Hackshaw AK, Stocks J, Elwood PC, Galton DJ. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Atheroscler Thromb 1994; 14: 1090-1097.
10. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou JP, Bard JM, Fruchart J-C, Apfelbaum M, Cambien F, Tiret L. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 1995; 36: 2141-2146.
11. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: Associations with hypertriglyceridemia and body mass index in obese people. Int J Obes 1995; 19: 270-274.
12. Anderson RE, Wadden TA, Bartlett SJ, Vogt RA, Weinstock RS. Relation of weight loss to changes in serum lipids and lipoproteins in obese women. Am J Clin Nutr 1995; 62: 350-357.
13. Wing RR, Jeffery RW. Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance? Int J Obes 1995; 19: 67-73.
14. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res 1995; 3 (SUPPL 2): 211S-216S.
15. National Institute of Health. Consensus Development Panel on the Health Implications of Obesity. Health implications of obesity. Ann Intern Med 1985; 103: 1073-1077.
16. Fricker J, Fumeron F, Clair D, Apfelbaum M. A positive correlation between energy intake and body mass index in a population of 1312 overweight subjects. Int J Obes 1989; 13: 663-691.
17. Wilkinson L. Systat, the system for statistics. Systat Inc: Evanston IL, 1990.
18. Ordovas JM, Lopez-Miranda J, Mata P, Perez-Gimenez F, Lichtenstein AH, Schaefer AJ. Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 1995; 118 (suppl): S11-S27.
19. Berg K. Predictive genetic testing to control coronary heart disease and hyperlipidaemia. Atherosclerosis 1989; 9 (suppl I): 1-51.
20. Weinsier RL, James LD, Darnell BE, Wooldridge NH, Birch R, Hunter GR, Bartolucci AA. Lipid and insulin concentrations in obese postmenopausal women: separate effects of energy restriction and weight loss. Am J Clin Nutr 1992; 56: 44-49.
21. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res 1995; 36: 2104-2112.22